NFKB1 and nasopharyngeal carcinoma: Inhibition of NF-κB signaling by the IκB kinase inhibitor PS-1145 results in downregulation of Qp-EBNA1 expression in cells of the EBV-positive NPC-derived cell line C666-1 [33].